Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
"Presidential Reelection Partner PLC" sounds more appropriate for the USA . My suggestion is "Gas for Douala Development"
D'oh
Indeed inanaco and Chelsea.
Almost six years after the 2013 Scancell investor update , some of which I understood, and Moditope news, the now even more spectacular SCIB1 trial results and welcome huge checkpoint inhibitor advances by others, I can't help wondering about what might have been , in terms of delay: getting Scancell products to many thousands of patients .
Why such delay?
Good news about IRC.
Does anyone know whether Collars for 50% is now a typical number for PROFITABLE iron ore producers?
Chelsea
Complement to excellent absolutely fascinating BBC4 story: I guess it might be an appropriate challenge for George McGavin to do a programme about NICE pricing of NHS drugs for terminal conditions.
Hello RetiredBanker,
I note your detailed , welcome, comments about spreads over government (Russian?) bonds and "Gazprombank, J.P. Morgan, Renaissance Capital and VTB Capital are acting as Joint Bookrunners in connection with the Offering." Would it be usual for a joint bookrunner such as J.P.Morgan to have a reasonable view about the bond spread?
For the avoidance of doubt, perhaps naively, I think conspiracy theories are most often wrong.
At the risk of asking a Baldrick war question.
I guess this is a 100 participant/patient Phase 1 trial which started last year of a combination of a checkpoint inhibitor with PF-06936308, does anyone here or outsider Pfizer know what is the history PF-06936308 ? and ….. does the vaccination hurt?
I think the share price could now reasonably be nearer 150p than 100p.
Three years ago the general perception of Egyptian political risk was arguably worse: President El--Sisi had only been in power since June 2014 and.... Egyptian football had no world class players?
However the Egyptian legal system is still even slower than the UK parliament/government.
Optimism from RetiredBanker, whatever next?
Maybe detailed numerical concerns about upping production from POX or processing others' gold?
Maybe POG should provide RNS updates on those two relatively new concerns throughout 2019?
Knowlesi
I have just looked at the Ichor website for anything about FDA delays: it was disappointing.
Unless good news is imminent, and anyway by (say) 29 March I think our BOD, should provide an, ideally RNS, update about about timing of the SCIB1+ Keytruda , UK+ USA, trial.